NASDAQ:LYEL

Lyell Immunopharma Stock Forecast

etoro logo Buy LYEL
*Your capital is at risk
$12.78
-0.0600 (-0.467%)
At Close: Jul 23, 2026
AI Analysis AI Analysis of LYEL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add LYEL to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Thursday for Lyell Immunopharma, Inc.
(Updated on Jul 23, 2026)

Sell candidate since Jul 16, 2026 Loss -7.99%

The Lyell Immunopharma, Inc. stock price fell by -0.467% on the last day (Thursday, 23rd Jul 2026) from $12.84 to $12.78. During the last trading day the stock fluctuated 3.37% from a day low at $12.60 to a day high of $13.02. The price has fallen in 8 of the last 10 days and is down by -15.98% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -72 thousand shares and in total, 91 thousand shares were bought and sold for approximately $1.17 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -38.15% during the next 3 months and, with a 90% probability hold a price between $5.58 and $8.78 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LYEL Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 10.08%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lyell Immunopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.30 and $13.32. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Lyell Immunopharma, Inc. stock

Lyell Immunopharma, Inc. finds support from accumulated volume at $12.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.425 between high and low, or 3.37%. For the last week the stock has had daily average volatility of 6.26%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LYEL) For The Upcoming Trading Day Of Friday 24th

For the upcoming trading day on Friday, 24th we expect Lyell Immunopharma, Inc. to open at $12.80, and during the day (based on 14 day Average True Range), to move between $12.20 and $13.36, which gives a possible trading interval of +/-$1.16 (+/-9.53%) up or down from last closing price. If Lyell Immunopharma, Inc. takes out the full calculated possible swing range there will be an estimated 9.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.74 (0.31%) than the resistance at $14.05 (9.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lyell Immunopharma, Inc. stock A Buy?

Lyell Immunopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.641 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 24, 2026 - $12.80 ( 0.143%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

LYEL Performance

Trading levels for LYEL

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 13.22 3.47%
R2 13.06 2.20%
R1 12.96 1.41%
Price 12.78
S1 12.64 -1.13%
S2 12.54 -1.91%
S3 12.37 -3.18%

Accumulated Volume Support & Resistance Levels

Level Price
R3 15.91 24.49%
R2 15.40 20.50%
R1 14.05 9.94%
Price 12.78
S1 12.74 -0.313%
S2 12.57 -1.64%
S3 11.61 -9.15%

FAQ

What is the symbol for Lyell Immunopharma, Inc. Stock and on which exchange is it traded?
The symbol for Lyell Immunopharma, Inc. is LYEL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lyell Immunopharma, Inc. Stock?
Lyell Immunopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Lyell Immunopharma, Inc. Stock?
Lyell Immunopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lyell Immunopharma, Inc. Stock.

What's the current price of Lyell Immunopharma, Inc. Stock?
As of the end of day on the Jul 23, 2026, the price of an Lyell Immunopharma, Inc. (LYEL) share was $12.78.

What is the 52-week high and low for Lyell Immunopharma, Inc. Stock?
The 52-week high for Lyell Immunopharma, Inc. Stock is $45.00 and the 52-week low is $9.28.

What is the market capitalization of Lyell Immunopharma, Inc. Stock?
As of the Jul 23, 2026, the market capitalization of Lyell Immunopharma, Inc. is 313.166M.

When is the next earnings date for Lyell Immunopharma, Inc.?
The upcoming earnings date for Lyell Immunopharma, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT LYELL IMMUNOPHARMA, INC.
Lyell Immunopharma
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ...
GOLDEN STAR
Ticker Change Signal Date
I
INTR
$5.62
1.25% Jul 20
DHT
$17.31
4.74% Jul 13
JLL
$299.78
8.09% Jun 24
NMRK
$15.02
2.13% Jun 24
ROP
$331.60
1.54% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE